Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Urology. 2017 Mar 1;103:250. doi: 10.1016/j.urology.2016.11.051

Author Reply to the Editorial Comment #16-02517

Jason M Scovell 1,*, Friedrich-Carl von Rundstedt 1,2,*, Shelly X Bian 1,3, Dominic Lee 1,4, Wesley A Mayer 1, Richard E Link 1
PMCID: PMC5659338  NIHMSID: NIHMS913786  PMID: 28259417

Main Text

Patients with suspected ureteropelvic junction obstruction (UPJO) and equivocal 99mTc-mercaptoacetyltriglycine (MAG3) diuretic renographic study constitute a diagnostic challenge. The tracer uptake and excretion curve during a nuclear renal scan are functions of complex interactions between renal function, collecting system volume, and outflow obstruction. This creates challenges in translating curve morphology into an easily reported yes or no answer concerning the presence or absence of obstruction. We defined a new measurement, P40, which is the percent of maximal tracer eliminated at 40 minutes, during MAG3 diuretic renography.1 P40 has increased sensitivity (73%) as compared to traditional T1/2 interpretation of the MAG3 renal scan (49%). Moreover, P40 is simple to calculate from standard renography curves and requires no protocol alterations or additional expense. Treatment goals for UPJO include symptom reduction (eg, pain) and reduction in infectious risk, as well as preservation of renal function. In this study of symptomatic patients rendered asymptomatic by surgery, postoperative P40 improved more consistently than T1/2, suggesting that P40 may be a more valuable surrogate marker for clinically significant obstruction.

As Meyer and Gorin correctly stress,2 we cannot determine what would have happened to kidney function for the symptomatic patients in this study had they not undergone surgical intervention. In general, whether pyeloplasty prevents long-term function deterioration for patients with suspected UPJO and equivocal evidence for obstruction on renal scan remains unknown. A recent cohort study by Ozayar and colleagues demonstrated that 96% of patients (n = 23 of 24) with equivocal UPJO had complete symptom resolution after minimally invasive pyeloplasty.3 Future work defining long-term renal function in patients with equivocal UPJO is certainly needed. It is clear from our data and the work by Ozayar et al that patients with symptomatic UPJO and equivocal MAG3 renography benefit from surgical intervention with respect to symptom reduction. The association between P40 and long-term renal functional preservation, though, deserves further study. We anticipate that P40, a simple measurement dependent on urine flow dynamics, may be useful in identifying those patients who would benefit most from pyeloplasty.

Footnotes

The authors declare no conflict of interest

References

  • 1.von Rundstedt FC, Bian SJ, Lee SX, Mayer D, Link REWA. Percent of tracer clearance at 40 min in MAG3 renal scans is more sensitive than T1/2 for symptomatic UPJ obstruction. Urology. 2017 doi: 10.1016/j.urology.2016.11.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Meyer A, Gorin MA. Percent of tracer clearance at 40 minutes in MAG3 renal scans is more sensitive than T1/2 for symptomatic UPJ obstruction [Editorial Comment] Urology. 2017 doi: 10.1016/j.urology.2016.11.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ozayar A, Friedlander JI, Shakir NA, Gahan JC, Cadeddu JA, Morgan MS. Equivocal ureteropelvic junction obstruction on diuretic renogram--should minimally invasive pyeloplasty be offered to symptomatic patients? The Journal of urology. 2015;193:1278–1282. doi: 10.1016/j.juro.2014.10.100. [DOI] [PubMed] [Google Scholar]

RESOURCES